Domino’s Pizza Target Increased and 4 Stock Analyses to Know Now
Albany Molecular Research Inc. (NASDAQ:AMRI): Current Price: $5.75
The company keeps its Buy rating by Sterne Agee who says that it’s unable to find a catalyst for the pullback in shares today. The firm predicts that the company will report strong Q4 results along with 2013 guidance above consensus.
Waters Corp. (NYSE:WAT): Current Price: $91.39
The company’s price target was increased by Mizuho after the company reported its Q4 results and outlook and the firm keeps its Buy rating on the stock. The firm believes that there is an upside to the company’s initial 2013 guidance.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
3D Systems Corp. (NYSE:DDD): Current Price: $68.49
Canaccord decided to raise its 3D Systems estimates and it reiterated its Buy rating due to the company’s ability to consolidate the 3D printing vertical and scarcity value of public plays.
Domino’s Pizza, Inc. (NYSE:DPZ): Current Price: $46.77
The company’s price target has been raised by Argus due to the firm’s belief that the company will be able to benefit from ongoing unit expansion and favorable operating leverage. The firm keeps its Buy rating on the stock.
Medivation, Inc. (NASDAQ:MDVN): Current Price: $57.12
According to William Blair, Johnson & Johnson’s (NYSE:JNJ) Q4 results this morning, including the downward trend of sales for its metastatic prostate cancer drug Zytiga, shows strength for Medivation’s Xtandi. The firm is convinced that J&J’s decreased sales of Zytiga in Q4 were mainly a result of competitor Xtandi’s U.S. launch in September. William Blair has decided to reiterate its Outperform rating on shares of Medivation, which have been trading up 4 percent to $57.10 after J&J’s results.